Literature DB >> 9713973

Antisense technology: selection and delivery of optimally acting antisense oligonucleotides.

S Akhtar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9713973     DOI: 10.3109/10611869808995877

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


× No keyword cloud information.
  5 in total

1.  Nanostructure of cationic lipid-oligonucleotide complexes.

Authors:  Sarah Weisman; Danielle Hirsch-Lerner; Yechezkel Barenholz; Yeshayahu Talmon
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

Review 2.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

3.  [Antisense oligonucleotides for therapy of cystic fibrosis. Inhibition of sodium absorption mediated by ENaC in nasal epithelial cells].

Authors:  K Sobczak; N Bangel-Ruland; J Semmler; H Lindemann; R Heermann; W-M Weber
Journal:  HNO       Date:  2009-11       Impact factor: 1.284

Review 4.  The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.

Authors:  Traian V Chirila; Piroska E Rakoczy; Kerryn L Garrett; Xia Lou; Ian J Constable
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

5.  Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting.

Authors:  Gyati Shilakari Asthana; Abhay Asthana; Dharm Veer Kohli; Suresh Prasad Vyas
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.